Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
about
Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosisAntipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology.Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.The new fluoroquinolones: A critical reviewHuman organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.Disposition kinetics of sparfloxacin in healthy, hepatopathic, and nephropathic conditions in chicken after single intravenous administration.
P2860
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@ast
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@en
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@nl
type
label
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@ast
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@en
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@nl
prefLabel
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@ast
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@en
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@nl
P1476
Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review
@en
P2093
P407
P478
37 Suppl A
P577
1996-05-01T00:00:00Z